Ophthalmology · Orlando, FL
NPI
1487699625
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1206 N Mills Ave
Orlando, FL, 32803
Phone (407) 228-4035
Groups this clinician bills Medicare through
Medicare paid, 2024
$136K
2,559 services
Medicare patients, 2024
376
Average age 76
Drug cost, 2024
$197K
2,434 prescriptions
Company payments, 2025
$499
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Parul Pal was code 92012 (ophthalmological e&m), 582 times for 266 patients. In total Parul Pal billed 2,559 services in 20 codes, and Medicare paid $136K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 582 | 266 | $63.16 | $37K |
| 92083 Vision, Hearing, and Speech Services | Office | 414 | 247 | $43.03 | $18K |
| 92014 Ophthalmological E&M | Office | 357 | 328 | $75.39 | $27K |
| 92250 Angiography | Office | 320 | 304 | $23.85 | $7,632 |
| 92020 Ophthalmological E&M | Office | 242 | 170 | $18.42 | $4,459 |
| 99214 Office E&M - Established | Office | 192 | 189 | $106.05 | $20K |
| 92133 Computerized Ophthalmic Imaging | Office | 151 | 149 | $26.89 | $4,060 |
| 92134 Computerized Ophthalmic Imaging | Office | 110 | 97 | $25.92 | $2,851 |
| 76519 Ultrasound - Nonspecific | Office | 40 | 33 | $47.24 | $1,889 |
| 92025 Test - Miscellaneous | Office | 34 | 28 | $25.99 | $884 |
| 99204 Office E&M - New | Office | 32 | 32 | $120.63 | $3,860 |
| 92285 Standard X-ray | Office | 31 | 28 | $16.77 | $520 |
By year: 2022 $139K for 2,459 services; 2023 $136K for 2,540 services; 2024 $136K for 2,559 services.
Medicare prescription drug claims, 2024
In 2024, the drug Parul Pal prescribed most often to Medicare patients was Latanoprost, with 551 prescriptions and refills. In total Parul Pal wrote 2,434 Medicare prescriptions that cost $197K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 551 | 956 | 121 | $4,825 |
| Azelastine Hcl Generic | 425 | 661 | 169 | $13K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 153 | 315 | 43 | $1,914 |
| Ketorolac Tromethamine Generic | 137 | 175 | 58 | $3,196 |
| Erythromycin Erythromycin Base | 134 | 147 | 73 | $1,533 |
| Epinastine Hcl Generic | 121 | 148 | 45 | $7,284 |
| Prednisolone Acetate Generic | 102 | 128 | 56 | $4,099 |
| Lumigan Bimatoprost | 86 | 114 | 20 | $31K |
| Restasis Cyclosporine | 66 | 90 | 22 | $45K |
| Dorzolamide Hcl Generic | 52 | 90 | 13 | $1,155 |
| Moxifloxacin Moxifloxacin Hcl | 50 | 50 | 37 | $1,364 |
| Brimonidine Tartrate Generic | 47 | 65 | Under 11 | $1,473 |
| Simbrinza Brinzolamide/Brimonidine Tart | 43 | 60 | 12 | $9,263 |
| Travoprost Generic | 43 | 75 | 12 | $6,452 |
| Timolol Maleate Generic | 42 | 57 | 14 | $1,448 |
Brand drugs: 668 claims; generic drugs: 1,766 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Parul Pal $499 ($499 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $205.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 5 | $205 |
| Bausch & Lomb Americas Inc. BLCO | 4 | $72.95 |
| Oyster Point Pharma, Inc. | 1 | $61.7 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $37.91 |
| LKC Technologies, Inc. | 1 | $35.95 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $22.88 |
| Dompe US, Inc. | 1 | $22.66 |
| Amgen Inc. AMGN | 1 | $20.23 |
| Alcon Vision LLC ALC | 1 | $19.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.